PLX icon

Protalix BioTherapeutics

44 hedge funds and large institutions have $160M invested in Protalix BioTherapeutics in 2014 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 6 closing their positions.

Holders
44
Holders Change
-1
Holders Change %
-2.22%
% of All Funds
1.27%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
12
Reduced
13
Closed
6
Calls
$152K
Puts
$4.18M
Net Calls
-$4.03M
Net Calls Change
-$1.87M
Name Holding Trade Value Shares
Change
Shares
Change %
NSEDCP
26
NJ State Employees Deferred Compensation Plan
New Jersey
$183K
Northern Trust
27
Northern Trust
Illinois
$162K +$10.5K +230 +7%
DIA
28
Denver Investment Advisors
Colorado
$145K +$49.6K +1,082 +52%
CCA
29
Catalyst Capital Advisors
New York
$137K
Goldman Sachs
30
Goldman Sachs
New York
$130K -$1.37K -30 -1%
HSBC Holdings
31
HSBC Holdings
United Kingdom
$129K +$129K +2,822 New
WC
32
Woodstock Corp
Massachusetts
$105K +$105K +2,300 New
ARTA
33
A.R.T. Advisors
New York
$77K -$19.6K -432 -20%
TC
34
TFS Capital
Pennsylvania
$71K -$53.7K -1,176 -43%
Citadel Advisors
35
Citadel Advisors
Florida
$70K -$23.2K -507 -25%
Jane Street
36
Jane Street
New York
$49K +$137 +3 +0.3%
Bank of America
37
Bank of America
North Carolina
$41K +$7.35K +160 +22%
U
38
UBS
Switzerland
$22K -$2.19K -49 -9%
TRCT
39
Tower Research Capital (TRC)
New York
$12K +$3.13K +68 +35%
JFA
40
JNBA Financial Advisors
Minnesota
$9K +$9K +200 New
Citigroup
41
Citigroup
New York
$3K -$6.37K -174 -68%
First Eagle Investment Management
42
First Eagle Investment Management
New York
-$2.72M -70,000 Closed
Two Sigma Investments
43
Two Sigma Investments
New York
-$208K -5,357 Closed
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
-$158K -4,060 Closed
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
-$123K -3,170 Closed
CL
46
CSS LLC
Illinois
-$94K -2,410 Closed
HCM
47
Highbridge Capital Management
New York
-$89K -2,296 Closed